Polyplus-transfection, of Strasbourg, France, which specializes in the development and marketing of reagents for drug delivery, gene therapy and transfection, has set up a user group called the "Polyplus in vivo consortium." Polyplus-transfection hopes that creating this international network of research scientists and clinicians who use its synthetic gene transfer reagents will boost the number of clinical …
No comments:
Post a Comment